Ignite Creation Date:
2024-05-06 @ 2:48 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02133053
Status:
COMPLETED
Last Update Posted:
2014-05-07
First Post:
2014-05-02
Brief Title:
Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray
Sponsor:
Bitop AG
Organization:
Bitop AG
Study Overview
Official Title:
Non Interventional Study of Ectoin Allergy Nasal Spray Compared to Beclomethasone Nasal Spray
Status:
COMPLETED
Status Verified Date:
2014-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a comparative open label parallel group non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray The patient applies Ectoin Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use The observation takes place over a period of 14 days Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None